-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Meridian Bioscience Inc quarterly Deferred Income Tax Assets, Net history and growth rate from Q3 2015 to Q4 2022.
- Meridian Bioscience Inc Deferred Income Tax Assets, Net for the quarter ending December 31, 2022 was $9.65M, a 9.5% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)